Copyright © 2001 by the European Society of Cardiology.
Editorial
Smoking, nicotine and thrombotic risk a role for platelet dependent thrombin generation?
Department of Medicine, Division of Clinical Pharmacology, Karolinski Hospital, Stockholm, Sweden
References
- Jadhav PP, Tofler GH. Hemostatic risk factors for cardiovascular disease. Willich SN, Muller JE. Triggering of Acute Coronary SyndromesImplications for Prevention. Dordecht, the Netherlands: Kluwer Academic Publishers; 1996. p. 135151
- Br Med J. 1994;308:81106
[Abstract/Free Full Text] - Hemker HC. Thrombin generation, an essential step in haemostasis and thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone; 1994. p. 477490
- Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:14221431[Abstract]
- Fitzgerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J. 1988;115:267271[CrossRef][ISI][Medline]
- Wennmalm
, Benthin G, Granström EF, Persson L, Winell S. Maintained hyperexcretion of thromboxane A2metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. Clin Physiol. 1993;13:257264[ISI][Medline]
- Dotevall A, R
ngemark C, Eriksson E, Kutti J, Wadenvik H, Wennmalm
. Cigarette smoking increases thromboxane A2formation without affecting platelet survival in young healthy females. Thromb Haemost. 1992;68:583588[ISI][Medline]
- Saareks V, Riutta A, Mucha I, Alanko J, Vapaatalo H. Nicotine and cotinine modulate eicosanoid production in human leukocytes and platelet rich plasma. Eur J Pharmacol. 1993;248:345349[CrossRef][ISI][Medline]
- Fuster V, Cheseboro JH, Frye RL, Elveback LR. Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation. 1981;63:546551
[Abstract/Free Full Text] - Mundal HH, Hjemdahl P, Gjesdal K. Acute effects of cigarette smoking on platelet function and plasma catecholamines in hypertensive and normotensive men. Am J Hypertens. 1998;11:677681[CrossRef][ISI][Medline]
- Hioki Y, Aoki N, Kawano K. Acute effects of smoking on platelet-dependent thrombin generation. Eur Heart J. 2000;21:5459
- Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J. 1994;128:711[CrossRef][ISI][Medline]
- Aoki I, Shimoyama K, Aoki N. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes. J Am Coll Cardiol. 1996;27:560566[Abstract]
- Ratnatunga CP, Edmondson SF, Rees GM, Kovacs IB. High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circulation. 1992;85:10771082
[Abstract/Free Full Text] - Wallén NH, Ladjevardi M. Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood. Thromb Res. 1998;92:189194[CrossRef][ISI][Medline]
- Lancet. 1998;351:233241[CrossRef][ISI][Medline]
- Li N, Wallén NH, Savi P, Hérault JP, Herbert JM. Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation. Blood Coag Fibrinol. 1998;9:507515[ISI][Medline]
- Fitch LL, Buchwald H, Matts JP, Johnson JW, Campos CT, Long JM. Effect of aspirin use on death and recurrent myocardial infarction in current and former cigarette smokers. Am Heart J. 1995;129:656662[CrossRef][ISI][Medline]
This article has been cited by other articles:
![]() |
A. L. Moens, C. J. Vrints, M. J. Claeys, J.-P. Timmermans, H. C. Champion, and D. A. Kass Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1971 - H1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Israel, G. Gronefeld, J. R. Ehrlich, Y.-G. Li, and S. H. Hohnloser Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care J. Am. Coll. Cardiol., January 7, 2004; 43(1): 47 - 52. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

